LB Pharmaceuticals, Inc. (LBRX)
43.04
-1.80
(-4.01%)
USD |
NASDAQ |
Sep 15, 16:00
43.90
+0.86
(+2.00%)
After-Hours: 20:00
LB Pharmaceuticals Price : 43.04 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 44.84 | 44.84 | 42.50 | 43.04 | 320547.0 |
| Sep 14, 2026 | 44.95 | 45.72 | 44.55 | 44.84 | 242778.0 |
| Sep 11, 2026 | 46.80 | 47.68 | 44.40 | 44.63 | 208383.0 |
| Sep 10, 2026 | 47.20 | 47.20 | 45.50 | 46.25 | 174792.0 |
| Sep 09, 2026 | 49.07 | 49.81 | 47.46 | 47.67 | 190142.0 |
| Sep 08, 2026 | 48.53 | 49.62 | 47.15 | 49.39 | 300998.0 |
| Sep 04, 2026 | 47.47 | 49.91 | 47.47 | 49.34 | 205964.0 |
| Sep 03, 2026 | 48.88 | 48.91 | 46.72 | 47.52 | 282475.0 |
| Sep 02, 2026 | 47.31 | 49.93 | 46.44 | 49.48 | 518387.0 |
| Sep 01, 2026 | 47.21 | 48.21 | 46.92 | 47.10 | 201987.0 |
| Aug 31, 2026 | 47.47 | 47.50 | 46.38 | 47.26 | 386951.0 |
| Aug 28, 2026 | 47.64 | 49.24 | 46.37 | 47.73 | 230559.0 |
| Aug 27, 2026 | 48.15 | 48.42 | 47.14 | 47.89 | 256078.0 |
| Aug 26, 2026 | 48.71 | 48.71 | 47.21 | 48.16 | 244901.0 |
| Aug 25, 2026 | 48.70 | 50.16 | 48.48 | 48.80 | 217026.0 |
| Aug 24, 2026 | 47.88 | 49.06 | 46.83 | 48.21 | 252690.0 |
| Aug 21, 2026 | 47.71 | 48.21 | 46.34 | 47.62 | 225828.0 |
| Aug 20, 2026 | 48.51 | 48.86 | 46.90 | 47.23 | 194528.0 |
| Aug 19, 2026 | 49.80 | 49.97 | 48.24 | 48.94 | 162252.0 |
| Aug 18, 2026 | 45.69 | 48.93 | 45.69 | 48.77 | 540387.0 |
| Aug 17, 2026 | 47.10 | 47.96 | 46.11 | 46.23 | 261785.0 |
| Aug 14, 2026 | 44.24 | 47.88 | 43.64 | 47.78 | 295402.0 |
| Aug 13, 2026 | 46.00 | 46.15 | 44.02 | 44.27 | 432903.0 |
| Aug 12, 2026 | 45.32 | 46.01 | 44.03 | 45.38 | 355992.0 |
| Aug 11, 2026 | 45.93 | 46.27 | 43.61 | 45.33 | 235758.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ligand Pharmaceuticals, Inc. | 276.98 |
| Neumora Therapeutics, Inc. | 0.8313 |
| ANI Pharmaceuticals, Inc. | 72.11 |
| Corcept Therapeutics, Inc. | 110.82 |
| Veru, Inc. | 2.34 |
Price Related Metrics
| PEG Ratio | -0.1093 |
| Price to Book Value | 3.714 |
| Earnings Yield | -6.93% |
| Market Cap | 1.234B |
| PEGY Ratio | -0.1093 |